These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 14602500

  • 1. Early and chronic captopril or Losartan therapy reduces infarct size and avoids congestive heart failure after myocardial infarction in rats.
    Martínez LA, Villalobos-Molina R.
    Arch Med Res; 2003; 34(5):357-61. PubMed ID: 14602500
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
    Parlakpinar H, Ozer MK, Acet A.
    Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.
    Belonje AM, Westenbrink BD, Voors AA, von Haehling S, Ponikowski P, Anker SD, van Veldhuisen DJ, Dickstein K.
    Am Heart J; 2009 Jan; 157(1):91-6. PubMed ID: 19081402
    [Abstract] [Full Text] [Related]

  • 8. The antithrombotic effect of captopril and losartan on experimental arterial thrombosis in rats.
    Chabielska E, Pawlak R, Golatowski J, Buczko W.
    J Physiol Pharmacol; 1998 Jun; 49(2):251-60. PubMed ID: 9670108
    [Abstract] [Full Text] [Related]

  • 9. Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy.
    Møller JE, Dahlström U, Gøtzsche O, Lahiri A, Skagen K, Andersen GS, Egstrup K, OPTIMAAL Study Group.
    Am Heart J; 2004 Mar; 147(3):494-501. PubMed ID: 14999200
    [Abstract] [Full Text] [Related]

  • 10. First dose hypotension after angiotensin converting enzyme inhibitor captopril and angiotensin II blocker losartan in patients with acute myocardial infarction.
    Spinar J, Vitovec J, Pluhacek L, Spinarova L, Fischerova B, Toman J.
    Int J Cardiol; 2000 Sep 15; 75(2-3):197-204. PubMed ID: 11077134
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Losartan inhibits myosin isoform shift after myocardial infarction in rats.
    Zhang ML, Elkassem S, Davidoff AW, Saito K, ter Keurs HE.
    Mol Cell Biochem; 2003 Sep 15; 251(1-2):111-7. PubMed ID: 14575312
    [Abstract] [Full Text] [Related]

  • 14. Survival after myocardial infarction in rats: captopril versus losartan.
    Milavetz JJ, Raya TE, Johnson CS, Morkin E, Goldman S.
    J Am Coll Cardiol; 1996 Mar 01; 27(3):714-9. PubMed ID: 8606287
    [Abstract] [Full Text] [Related]

  • 15. [A-II blocker or ACE inhibitor in heart failure? Captopril can't be beat].
    Einecke D.
    MMW Fortschr Med; 1999 Nov 25; 141(47):4-5. PubMed ID: 10912155
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [ACE inhibitors or AT1 receptor antagonists?].
    Riegger GA.
    Dtsch Med Wochenschr; 1999 Sep 24; 124 Suppl 2():S37-9. PubMed ID: 10535045
    [No Abstract] [Full Text] [Related]

  • 18. The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure.
    Sato T, Yoshimura R, Kawada T, Shishido T, Miyano H, Sugimachi M, Sunagawa K.
    J Card Fail; 1998 Jun 24; 4(2):139-44. PubMed ID: 9730108
    [Abstract] [Full Text] [Related]

  • 19. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    McMurray J, Solomon S, Pieper K, Reed S, Rouleau J, Velazquez E, White H, Howlett J, Swedberg K, Maggioni A, Køber L, Van de Werf F, Califf R, Pfeffer M.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):726-33. PubMed ID: 16487836
    [Abstract] [Full Text] [Related]

  • 20. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.
    Dickstein K, Kjekshus J, OPTIMAAL Steering Committee of the OPTIMAAL Study Group.
    Lancet; 2002 Sep 07; 360(9335):752-60. PubMed ID: 12241832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.